These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23613563)

  • 1. Targeting purinergic receptors in islet transplantation.
    Aikin RA
    Diabetes; 2013 May; 62(5):1394-5. PubMed ID: 23613563
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection.
    Vergani A; Fotino C; D'Addio F; Tezza S; Podetta M; Gatti F; Chin M; Bassi R; Molano RD; Corradi D; Gatti R; Ferrero ME; Secchi A; Grassi F; Ricordi C; Sayegh MH; Maffi P; Pileggi A; Fiorina P
    Diabetes; 2013 May; 62(5):1665-75. PubMed ID: 23315496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic biopsy of islet transplants in the gastric submucosal space provides evidence of islet graft rejection in diabetic pigs.
    Tanaka T; Fujita M; Bottino R; Piganelli JD; McGrath K; Li J; Lee W; Iwase H; Wijkstrom M; Bertera S; Long C; Landsittel D; Haruma K; Cooper DK; Hara H
    Islets; 2016; 8(1):1-12. PubMed ID: 26857703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the purinergic pathway prolongs mouse lung allograft survival.
    Liu K; Vergani A; Zhao P; Ben Nasr M; Wu X; Iken K; Jiang D; Su X; Fotino C; Fiorina P; Visner GA
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):300-10. PubMed ID: 24661183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7.
    Vergani A; Tezza S; D'Addio F; Fotino C; Liu K; Niewczas M; Bassi R; Molano RD; Kleffel S; Petrelli A; Soleti A; Ammirati E; Frigerio M; Visner G; Grassi F; Ferrero ME; Corradi D; Abdi R; Ricordi C; Sayegh MH; Pileggi A; Fiorina P
    Circulation; 2013 Jan; 127(4):463-75. PubMed ID: 23250993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7.
    Hattori F; Ohshima Y; Seki S; Tsukimoto M; Sato M; Takenouchi T; Suzuki A; Takai E; Kitani H; Harada H; Kojima S
    Eur J Pharmacol; 2012 Nov; 695(1-3):20-6. PubMed ID: 22981895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P2X7 receptor antagonist, oxidized adenosine triphosphate, ameliorates renal ischemia-reperfusion injury by expansion of regulatory T cells.
    Koo TY; Lee JG; Yan JJ; Jang JY; Ju KD; Han M; Oh KH; Ahn C; Yang J
    Kidney Int; 2017 Aug; 92(2):415-431. PubMed ID: 28396117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2X7 receptor antagonism inhibits p38 mitogen-activated protein kinase activation and ameliorates neuronal apoptosis after subarachnoid hemorrhage in rats.
    Chen S; Ma Q; Krafft PR; Chen Y; Tang J; Zhang J; Zhang JH
    Crit Care Med; 2013 Dec; 41(12):e466-74. PubMed ID: 23963136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
    Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
    Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy.
    Jimenez-Pacheco A; Diaz-Hernandez M; Arribas-Blázquez M; Sanz-Rodriguez A; Olivos-Oré LA; Artalejo AR; Alves M; Letavic M; Miras-Portugal MT; Conroy RM; Delanty N; Farrell MA; O'Brien DF; Bhattacharya A; Engel T; Henshall DC
    J Neurosci; 2016 Jun; 36(22):5920-32. PubMed ID: 27251615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the P2X7 purinergic receptor in inflammation: an update of antagonists series since 2009 and their promising therapeutic potential.
    Baudelet D; Lipka E; Millet R; Ghinet A
    Curr Med Chem; 2015; 22(6):713-29. PubMed ID: 25515510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first CNS-active carborane: A novel P2X7 receptor antagonist with antidepressant activity.
    Wilkinson SM; Gunosewoyo H; Barron ML; Boucher A; McDonnell M; Turner P; Morrison DE; Bennett MR; McGregor IS; Rendina LM; Kassiou M
    ACS Chem Neurosci; 2014 May; 5(5):335-9. PubMed ID: 24689484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2X7 receptors in the central nervous system.
    Miras-Portugal MT; Ortega F; Gómez-Villafuertes R; Gualix J; Pérez-Sen R; Delicado EG
    Biochem Pharmacol; 2021 May; 187():114472. PubMed ID: 33587917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia.
    Arbeloa J; Pérez-Samartín A; Gottlieb M; Matute C
    Neurobiol Dis; 2012 Mar; 45(3):954-61. PubMed ID: 22186422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of P2X7 receptors in tissue fibrosis: a brief review.
    Gentile D; Natale M; Lazzerini PE; Capecchi PL; Laghi-Pasini F
    Purinergic Signal; 2015 Dec; 11(4):435-40. PubMed ID: 26318434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease.
    Geraghty NJ; Belfiore L; Ly D; Adhikary SR; Fuller SJ; Varikatt W; Sanderson-Smith ML; Sluyter V; Alexander SI; Sluyter R; Watson D
    Clin Exp Immunol; 2017 Oct; 190(1):79-95. PubMed ID: 28665482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of P2X₃ and P2X₇ purinergic receptors activated by ATP in rat lacrimal gland.
    Hodges RR; Vrouvlianis J; Scott R; Dartt DA
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3254-63. PubMed ID: 21421865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine epidermal Langerhans cells and keratinocytes express functional P2X7 receptors.
    Tran JN; Pupovac A; Taylor RM; Wiley JS; Byrne SN; Sluyter R
    Exp Dermatol; 2010 Aug; 19(8):e151-7. PubMed ID: 20113349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc enhances long-term potentiation through P2X receptor modulation in the hippocampal CA1 region.
    Lorca RA; Rozas C; Loyola S; Moreira-Ramos S; Zeise ML; Kirkwood A; Huidobro-Toro JP; Morales B
    Eur J Neurosci; 2011 Apr; 33(7):1175-1185. PubMed ID: 21324005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 2.
    Brumfield S; Matasi JJ; Tulshian D; Czarniecki M; Greenlee W; Garlisi C; Qiu H; Devito K; Chen SC; Sun Y; Bertorelli R; Ansell J; Geiss W; Le VD; Martin GS; Vellekoop SA; Haber J; Allard ML
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7287-90. PubMed ID: 22078214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.